The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Modification of the Terminal Residue of Apelin-13 Antagonizes Its Hypotensive Action
Abstract
The apelin peptide is the endogenous ligand for the apelin G protein-coupled receptor. The distribution of the apelin peptides and receptor are widespread in the central nervous system and periphery, with reported roles in the hypothalamic-pituitary-adrenal axis, blood pressure regulation and as one of the most potent positive inotropic substances yet identified. In this report, we show that in native tissues preproapelin exists as a dimer. Dimeric preproapelin was reduced to monomers by dithiothreitol treatment, indicating disulfide linkages. To evaluate the role of the carboxyl-terminal phenylalanine in the hypotensive action of apelin-13, analogs were generated and tested for their role on blood pressure regulation. Injections of apelin-13 and apelin-12 (15 μg/kg) into spontaneously hypertensive rats lowered systolic and diastolic blood pressure to result in decreases of approximately 60% and 15% in mean arterial blood pressure, respectively. Apelin-13(13[d-Phe]) treatment did not differ from apelin-13 in either efficacy or duration of effect, whereas apelin-13(F13A) revealed a loss of function. However, concomitant administration of apelin-13(F13A) (30 μg/kg) blocked hypotensive effects of apelin-13 (15 μg/kg), which revealed that apelin-13(F13A) behaved as an apelin-specific antagonist.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptor
Tatemoto, K., Hosoya, M., Habata, Y., Fujii, R., Kakegawa, T., Zou, M.-X., Kawamata, Y., Fukusumi, S., Hinuma, S., Kitada, C., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9489 · Cited by 1,685
Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
O'Dowd, B. F., Heiber, M., Chan, A., Heng, H. H. Q., Tsui, L.-C., Kennedy, J. L., Shi, X., Petronis, A., George, S. R., & Nguyen, T. (1993) · Gene · doi:10.1016/0378-1119(93)90495-o · Cited by 851
Self-citationCharacterization of Apelin, the Ligand for the APJ Receptor
Lee, D. K., Cheng, R., Nguyen, T., Fan, T., Kariyawasam, A. P., Liu, Y., Osmond, D. H., George, S. R., & O'Dowd, B. F. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740034.x · Cited by 682
Self-citationThe novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism
Tatemoto, K., Takayama, K., Zou, M.-X., Kumaki, I., Zhang, W., Kumano, K., & Fujimiya, M. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(01)00236-1 · Cited by 640
Apelin, the Novel Endogenous Ligand of the Orphan Receptor APJ, Regulates Cardiac Contractility
Szokodi, I., Tavi, P., Földes, G., Voutilainen-Myllylä, S., Ilves, M., Tokola, H., Pikkarainen, S., Piuhola, J., Rysä, J., Tóth, M., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000033522.37861.69 · Cited by 625
Molecular properties of apelin: tissue distribution and receptor binding
Kawamata, Y., Habata, Y., Fukusumi, S., Hosoya, M., Fujii, R., Hinuma, S., Nishizawa, N., Kitada, C., Onda, H., Nishimura, O., et al. (2001) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(00)00143-9 · Cited by 521
Molecular and Functional Characteristics of APJ
Hosoya, M., Kawamata, Y., Fukusumi, S., Fujii, R., Habata, Y., Hinuma, S., Kitada, C., Honda, S., Kurokawa, T., Onda, H., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m908417199 · Cited by 483
Medhurst, A. D., Jennings, C. A., Robbins, M. J., Davis, R. P., Ellis, C., Winborn, K. Y., Lawrie, K. W. M., Hervieu, G., Riley, G., Bolaky, J. E., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01587.x · Cited by 448
Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain
Reaux, A., De Mota, N., Skultetyova, I., Lenkei, Z., El Messari, S., Gallatz, K., Corvol, P., Palkovits, M., & Llorens‐Cortès, C. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00320.x · Cited by 374
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Kuba, K., Imai, Y., Ohto-Nakanishi, T., & Penninger, J. M. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.003 · Cited by 480
Microscale Fluorescent Thermal Stability Assay for Membrane Proteins
Alexandrov, A. I., Mileni, M., Chien, E. Y. T., Hanson, M. A., & Stevens, R. C. (2008) · Structure · doi:10.1016/j.str.2008.02.004 · Cited by 449
Emerging roles of apelin in biology and medicine
Kleinz, M. J., & Davenport, A. P. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.001 · Cited by 413
The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis
O'Carroll, A.-M., Lolait, S. J., Harris, L. E., & Pope, G. R. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0227 · Cited by 344
Japp, A. G., Cruden, N. L., Barnes, G., van Gemeren, N., Mathews, J., Adamson, J., Johnston, N. R., Denvir, M. A., Megson, I. L., Flapan, A. D., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.911339 · Cited by 328
Maguire, J. J., Kleinz, M. J., Pitkin, S. L., & Davenport, A. P. (2009) · Hypertension · doi:10.1161/hypertensionaha.109.134619 · Cited by 323
Kuba, K., Zhang, L., Imai, Y., Arab, S., Chen, M., Maekawa, Y., Leschnik, M., Leibbrandt, A., Markovic, M., Schwaighofer, J., et al. (2007) · Circulation Research · doi:10.1161/circresaha.107.158659 · Cited by 308
Castan-Laurell, I., Dray, C., Attané, C., Duparc, T., Knauf, C., & Valet, P. (2011) · Endocrine · doi:10.1007/s12020-011-9507-9 · Cited by 297
The hepatic apelin system: A new therapeutic target for liver disease†
Principe, A., Melgar‐Lesmes, P., Fernández‐Varo, G., del Arbol, L. R., Ros, J., Morales‐Ruiz, M., Bernardi, M., Arroyo, V., & Jiménez, W. (2008) · Hepatology · doi:10.1002/hep.22467 · Cited by 127
Apelin/APJ system: A novel therapeutic target for locomotor system diseases
Luo, J., Liu, W., Feng, F., & Chen, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174286 · Cited by 28
Metadata
- Authors
- Lee, D. K., Saldivia, V. R., Nguyen, T., Cheng, R., George, S. R., & O’Dowd, B. F.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2005-01-01
- Volume
- 146
- Issue
- 1
- Pages
- 231-236
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2066996500
- Cited by
- 256
- References
- 26
- FWCI
- 3.72
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.